Xuesong Wen
London, ENG NW44BT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The Therapeutic Effect of EZH2 Inhibitors in Targeting Human Papillomavirus Associated Cervical Cancer.
Journal: Current issues in molecular biology
Published: October 31, 2025
Optimisation of Folate-Mediated Liposomal Encapsulated Arsenic Trioxide for Treating HPV-Positive Cervical Cancer Cells In Vitro.
Journal: International journal of molecular sciences
Published: April 10, 2019
Separation and purification using GO and r-GO membranes.
Journal: RSC advances
Published: April 13, 2018
Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study.
Journal: International journal of molecular sciences
Published: February 20, 2018
Liposome‑delivered baicalein induction of myeloid leukemia K562 cell death via reactive oxygen species generation.
Journal: Molecular medicine reports
Published: September 11, 2017
Recent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancers.
Journal: Journal of biomedical research
Published: August 16, 2017
Modeling and validating three dimensional human normal cervix and cervical cancer tissues in vitro.
Journal: Journal of biomedical research
Published: August 16, 2017
Therapeutic Potential of Delivering Arsenic Trioxide into HPV-Infected Cervical Cancer Cells Using Liposomal Nanotechnology.
Journal: Nanoscale research letters
Published: November 26, 2015
Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populations.
Journal: Anti-cancer drugs
Published: January 17, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026